Forecast: Pharmaceuticals in Dosage Market Size Value in the UK

The UK pharmaceuticals in dosage market has experienced significant fluctuations from 2013 to 2023. The market peaked in 2015 with a value of $106.96 billion but saw a notable decline through 2017, reaching $81.808 billion. The decline continued through 2019, and while there was a minor recovery in 2020, the overall trend remained downward, with the market positioned at $69.574 billion in 2023. The average year-on-year variation over the last two years stood at -0.43%, indicating a stabilization but at a lower market value. The average CAGR from 2019 to 2023 was -2.13%.

Looking forward, the forecast from 2024 to 2028 suggests continual but modest decline, with a forecasted 5-year CAGR of -0.34% and a projected market value decrease to $68.108 billion by 2028.

Future trends to watch for include the impact of Brexit on pharmaceutical regulations, potential advancements in biotechnology and personalized medicine, and shifts in healthcare policies that could influence market dynamics. Additionally, monitoring the global supply chain and its effects on the UK market remains crucial.